Related Experiment Video
Updated: Jun 12, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Resolution of extensive severe bronchiectasis in an infant
Suzanne Crowley1, Iren Matthews
1Barneklinikken, Unit for Paediatric Heart, Lung, Allergic Diseases, Rikshospitalet, Oslo, Norway. suzanne.crowley@rikshospitalet.no
Pediatric Pulmonology
|June 25, 2010
Summary
Severe bronchiectasis in an infant unexpectedly resolved after prolonged antibiotic and steroid treatment. This case suggests potential reversibility and highlights the role of infection eradication in bronchial regeneration.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
Background:
- Bronchiectasis is conventionally defined as irreversible airway dilation.
- Recent findings suggest potential reversibility in pediatric cases, prompting reevaluation of the definition.
- This includes considering pre-bronchiectasis and transitional reversible states.
Observation:
- A case of a young infant with severe, extensive bronchiectasis of unknown cause is presented.
- The infant underwent prolonged treatment with antibiotics and a tapering course of oral steroids.
- Remarkably, the bronchiectasis showed complete resolution.
Findings:
- The resolution of severe bronchiectasis in this infant following treatment is a significant clinical observation.
- Prolonged antibiotic therapy may have eradicated underlying infection.
- This eradication potentially facilitated the regeneration of bronchial anatomy.
Implications:
- This case challenges the traditional definition of bronchiectasis as irreversible.
- It suggests that certain forms of pediatric bronchiectasis may be reversible.
- Further research into the mechanisms of bronchial regeneration and the role of infection is warranted.
Related Concept Videos
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.